This site is intended for health professionals only

Published on 12 July 2007

Share this story:

Third-phase success for RA drug


Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: